Named Bioactive Compounds · Compound
Carnosine (Dipeptide)
Strong Evidenceother_bioactive
Hermetica Superfood Encyclopedia
Carnosine is a naturally occurring dipeptide composed of β-alanine and L-histidine, synthesized endogenously, playing a crucial role as an antioxidant, anti-glycation agent, and acid buffer in excitable tissues. It effectively neutralizes lactic acid, scavenges free radicals, and inhibits protein glycation to protect cellular integrity.
Carnosine is a dipeptide composed of β-alanine and L-histidine, endogenously synthesized in muscle, brain, heart, and gastrointestinal tissues of vertebrates but not found in plants. Commercially, it is produced synthetically or via enzymatic synthesis rather than extracted from natural sources, occurring naturally at high concentrations of 17-25 mmol/kg dry muscle.
The research dossier indicates that search results lack specific details on key human clinical trials, RCTs, or meta-analyses for carnosine supplementation. No PubMed PMIDs, study designs, sample sizes, or clinical outcomes are provided in the available sources.
No clinically studied dosage ranges, forms, or standardization details are specified in the available research. Consult a healthcare provider before starting any new supplement.
Carnosine (β-alanyl-L-histidine) is an endogenous dipeptide composed of β-alanine and L-histidine, with a molecular weight of 226.23 g/mol. It is not a traditional nutrient but a bioactive compound found predominantly in skeletal muscle and brain tissue. Key profile: • Concentration in human skeletal muscle: ~20-30 mmol/kg dry weight (type II fast-twitch fibers contain ~30-50% more than type I slow-twitch fibers) • Concentration in brain tissue: ~0.5-2.0 mmol/kg wet weight, primarily in olfactory bulb and select regions • Dietary sources: exclusively found in animal-derived foods — beef (~350-500 mg per 100g raw), chicken breast (~400-600 mg per 100g raw), pork (~200-400 mg per 100g raw), fish (~0-50 mg per 100g, generally very low); absent from plant-based foods entirely • Bioavailability: oral carnosine is rapidly hydrolyzed by serum carnosinase (CN1, EC 3.4.13.20) in human plasma, yielding β-alanine and L-histidine; intact dipeptide bioavailability is estimated at only ~10-15% due to first-pass hydrolysis; β-alanine is the rate-limiting precursor for intramuscular carnosine synthesis via carnosine synthase (EC 6.3.2.11) • Supplementation context: direct carnosine supplementation (typical doses 500-2000 mg/day) is less efficient at raising muscle carnosine than supplementing with β-alanine (3.2-6.4 g/day), which increases muscle carnosine by ~40-80% over 4-10 weeks • Contains no vitamins, minerals, fiber, or caloric energy in meaningful amounts • Related compounds in muscle tissue: anserine (β-alanyl-N1-methylhistidine) and balenine (β-alanyl-N3-methylhistidine) serve similar buffering roles; anserine is more abundant in poultry and fish • The imidazole ring of the histidine moiety (pKa ~6.83) is responsible for pH buffering capacity in the physiological intramuscular pH range (6.0-7.0) • Also possesses anti-glycation activity — reacts with methylglyoxal and other reactive carbonyl species, potentially reducing advanced glycation end-product (AGE) formation • Metal chelation involves binding of Cu²⁺, Zn²⁺, and Fe²⁺ ions via the imidazole nitrogen and amino/carboxyl groups, with stability constants (log K) of approximately 8.5 for Cu²⁺ and 4.5 for Zn²⁺
Carnosine primarily exerts its effects through multiple mechanisms: as an antioxidant by directly scavenging free oxygen radicals and aldehydes, as an anti-glycation agent inhibiting the formation of advanced glycation end-products (AGEs), and as a metal chelator. It also buffers lactic acid in excitable tissues to maintain acid-alkaline balance, and modulates calcium channels in muscle cells to enhance performance.
Extensive research, including numerous in vitro and animal studies, has consistently demonstrated Carnosine's potent antioxidant and anti-glycation properties. Human clinical trials, often involving athletes or older adults, have shown its efficacy in enhancing muscle performance by buffering lactic acid and reducing fatigue. Emerging evidence from smaller-scale human studies also suggests potential benefits for cognitive function and cardiovascular health, though larger, more definitive trials are needed to confirm these benefits.
Carnosine is generally considered safe and well-tolerated when taken at recommended dosages. Mild gastrointestinal upset, such as nausea or indigestion, has been reported in rare cases. There are no significant or well-established drug interactions with Carnosine; however, individuals on medications for blood sugar regulation or blood pressure should consult a healthcare provider. Due to limited research on its effects during pregnancy and lactation, its use is not recommended for pregnant or breastfeeding women without medical supervision.
